These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 890205

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR, Youdim MB.
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [Abstract] [Full Text] [Related]

  • 3. Preferential deamination of dopamine by an A type monoamine oxidase in rat brain.
    Waldmeier PC, Delini-Stula A, Maître L.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Nov; 292(1):9-14. PubMed ID: 934359
    [Abstract] [Full Text] [Related]

  • 4. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.
    Grahame-Smith DG.
    J Neurochem; 1971 Jun; 18(6):1053-66. PubMed ID: 4254940
    [No Abstract] [Full Text] [Related]

  • 5. Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain.
    Garrick NA, Murphy DL.
    Psychopharmacology (Berl); 1980 Jun; 72(1):27-33. PubMed ID: 6781004
    [No Abstract] [Full Text] [Related]

  • 6. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
    Fagervall I, Ross SB.
    J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
    [Abstract] [Full Text] [Related]

  • 7. Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359.
    Kumagae Y, Matsui Y, Iwata N.
    Jpn J Pharmacol; 1991 Jan; 55(1):121-8. PubMed ID: 1904113
    [Abstract] [Full Text] [Related]

  • 8. The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions.
    O'Carroll AM, Fowler CJ, Phillips JP, Tobbia I, Tipton KF.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Apr; 322(3):198-202. PubMed ID: 6408492
    [Abstract] [Full Text] [Related]

  • 9. Responses of developing rats to L-tryptophan plus an MAOI-I. Monitoring changes in behaviour, brain 5-HT and tryptophan.
    Atterwill CK, Green AR.
    Neuropharmacology; 1980 Apr; 19(4):325-35. PubMed ID: 7383278
    [No Abstract] [Full Text] [Related]

  • 10. Quipazine: its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour.
    Green AR, Youdim MB, Grahame-Smith DG.
    Neuropharmacology; 1976 Mar; 15(3):173-9. PubMed ID: 132619
    [No Abstract] [Full Text] [Related]

  • 11. The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.
    Green AR, Grahame-Smith DG.
    Neuropharmacology; 1974 Nov; 13(10-11):949-59. PubMed ID: 4437730
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA, Zagorevskiĭ VA, Lopatina KI, Sokolova TV, Gankina EM.
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [Abstract] [Full Text] [Related]

  • 13. The deamination of noradrenaline and 5-hydroxytryptamine by rat brain and heart monoamine oxidase and their inhibition by cimoxatone, toloxatone and MD 770222.
    Strolin Benedetti M, Boucher T, Fowler CJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Aug; 323(4):315-20. PubMed ID: 6633672
    [Abstract] [Full Text] [Related]

  • 14. Selective inhibition of the A form of monoamine oxidase by 4-dimethylamino-alpha-methylphenylalkylamine derivatives in the rat.
    Ask AL, Hellström W, Norrman S, Ogren SO, Ross SB.
    Neuropharmacology; 1982 Apr; 21(4):299-308. PubMed ID: 7088264
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of MAO-A fails to alter cocaine-induced increases in extracellular dopamine and norepinephrine in rat nucleus accumbens.
    Pepper JP, Baumann MH, Ayestas M, Rothman RB.
    Brain Res Mol Brain Res; 2001 Mar 05; 87(2):184-9. PubMed ID: 11245920
    [Abstract] [Full Text] [Related]

  • 16. Effect of selective monoamine oxidase inhibitors on rat brain mitochondrial monoamine oxidase during hyperbaric oxygenation.
    Goroshinskaya IA, Bronovizkaya ZG, Gorkin VZ.
    Commun Psychopharmacol; 1977 Mar 05; 1(1):39-47. PubMed ID: 606471
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO).
    Fitzgerald DH, Tipton KF.
    J Neural Transm (Vienna); 2002 Mar 05; 109(3):251-65. PubMed ID: 11956949
    [Abstract] [Full Text] [Related]

  • 18. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan.
    Sleight AJ, Marsden CA, Martin KF, Palfreyman MG.
    Br J Pharmacol; 1988 Feb 05; 93(2):303-10. PubMed ID: 2451963
    [Abstract] [Full Text] [Related]

  • 19. The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.
    Fowler CJ, Benedetti MS.
    J Neurochem; 1983 Jun 05; 40(6):1534-41. PubMed ID: 6406646
    [Abstract] [Full Text] [Related]

  • 20. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB, Angers M.
    Biochem Pharmacol; 1987 May 15; 36(10):1731-5. PubMed ID: 3109430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.